{"disease":{"id":"diabetic-peripheral-neuropathic-pain","name":"diabetic peripheral neuropathic pain"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06546202","title":"Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China","phase":"","overall_status":"COMPLETED","enrollment_count":1271,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT06628908","title":"Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1100,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT07231419","title":"Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":734,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT06812117","title":"A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":721,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT04647773","title":"To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":687,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT06203002","title":"A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":496,"lead_sponsor_name":"Lexicon Pharmaceuticals","has_results":false},{"nct_id":"NCT06696443","title":"Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":455,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT04094662","title":"A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":393,"lead_sponsor_name":"Daiichi Sankyo Co., Ltd.","has_results":false},{"nct_id":"NCT06619860","title":"Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT04146896","title":"Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":228,"lead_sponsor_name":"Aptinyx","has_results":true},{"nct_id":"NCT04953221","title":"The Effect of YJ001 on Diabetic Peripheral Neuropathic Pain.","phase":"","overall_status":"UNKNOWN","enrollment_count":225,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06221241","title":"Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT05895552","title":"A Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":209,"lead_sponsor_name":"Reata, a wholly owned subsidiary of Biogen","has_results":true},{"nct_id":"NCT06490445","title":"A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Syqe Medical","has_results":false},{"nct_id":"NCT04688671","title":"Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Eliem Therapeutics (UK) Ltd.","has_results":true},{"nct_id":"NCT05177094","title":"Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT05620576","title":"A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05).","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT04476108","title":"Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT06490484","title":"Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT04707157","title":"Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":68,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT06737861","title":"Buerger Exercises With Whole Body Vibration in Diabetic Peripheral Neuropathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT07126197","title":"Using Lymphovenous Bypass to Alleviate Diabetic Peripheral Neuropathy","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":60,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT05766969","title":"Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":52,"lead_sponsor_name":"Pure Green Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT04679545","title":"Using Cannabidiol to Treat Diabetic Peripheral Neuropathy of the Feet","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Pure Green","has_results":false},{"nct_id":"NCT03909841","title":"Neuropathic Pain in Elderly People With Diabetes: Impact on Quality of Life and Cognition","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Queen Elizabeth Hospital, Hong Kong","has_results":false},{"nct_id":"NCT05349357","title":"Slider Versus Tensioner Neural Mobilization in Diabetic Peripheral Neuropathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT07209514","title":"Medtronic Inceptiv™ Closed-Loop DTM Spinal Cord Stimulation for Painful Diabetic Peripheral Neuropathy","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":25,"lead_sponsor_name":"TriCity Research Center","has_results":false},{"nct_id":"NCT06361108","title":"MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT04833660","title":"rTMS on Diabetic Peripheral Neuropathic Pain","phase":"NA","overall_status":"UNKNOWN","enrollment_count":22,"lead_sponsor_name":"Min Cheol Chang","has_results":false},{"nct_id":"NCT07298408","title":"Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Florida A&M University","has_results":false},{"nct_id":"NCT05296642","title":"Exercise Induced Hypoalgesia Diabetes","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT00071708","title":"Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Eli Lilly and Company","has_results":false}],"total":32},"guidelines":[{"drug_id":"duloxetine","guideline_body":"FDA label","recommendation":"Duloxetine is indicated for the treatment of diabetic peripheral neuropathic pain in adults.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null}],"source":"Drug Landscape verified database"}